Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Unitedhealth Group Inc (NYSE: UNH) closed at $454.11 down -22.38% from its previous closing price of $585.04. In other words, the price has decreased by -$22.38 from its previous closing price. On the day, 29.03 million shares were traded. UNH stock price reached its highest trading level at $489.53 during the session, while it also had its lowest trading level at $447.1201.
Ratios:
For a deeper understanding of Unitedhealth Group Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.88 whereas as Long-Term Debt/Eq ratio is at 0.77.
On January 06, 2025, Truist reiterated its Buy rating and also upped its target price recommendation from $625 to $610.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 17 ’25 when FLYNN TIMOTHY PATRICK bought 1,000 shares for $511.57 per share. The transaction valued at 511,575 led to the insider holds 4,500 shares of the business.
McSweeney Erin sold 701 shares of UNH for $438,987 on Nov 11 ’24. The EVP & Chief People Officer now owns 7,105 shares after completing the transaction at $626.23 per share. On Nov 11 ’24, another insider, McSweeney Erin, who serves as the Officer of the company, bought 701 shares for $626.23 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 415379849216 and an Enterprise Value of 468210974720. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.98, and their Forward P/E ratio for the next fiscal year is 13.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.86. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.01 while its Price-to-Book (P/B) ratio in mrq is 4.48. Its current Enterprise Value per Revenue stands at 1.142 whereas that against EBITDA is 12.92.
Stock Price History:
The Beta on a monthly basis for UNH is 0.46, which has changed by -0.0755654 over the last 52 weeks, in comparison to a change of 0.05430484 over the same period for the S&P500. Over the past 52 weeks, UNH has reached a high of $630.73, while it has fallen to a 52-week low of $438.50. The 50-Day Moving Average of the stock is -11.49%, while the 200-Day Moving Average is calculated to be -17.37%.
Shares Statistics:
For the past three months, UNH has traded an average of 5.17M shares per day and 9846020 over the past ten days. A total of 914.71M shares are outstanding, with a floating share count of 912.76M. Insiders hold about 0.21% of the company’s shares, while institutions hold 89.88% stake in the company. Shares short for UNH as of 1743379200 were 10868412 with a Short Ratio of 2.10, compared to 1740700800 on 8693946. Therefore, it implies a Short% of Shares Outstanding of 10868412 and a Short% of Float of 1.1900000000000002.
Dividends & Splits
According to the company, the forward annual dividend rate for UNH is 8.40, from 8.4 in the trailing year. Against a Trailing Annual Dividend Yield of 0.014357992The stock’s 5-year Average Dividend Yield is 1.35. The current Payout Ratio is 52.75% for UNH, which recently paid a dividend on 2025-03-10 with an ex-dividend date of 1741564800. Stock splits for the company last occurred on 2005-05-31 when the company split stock in a 2:1 ratio.
Earnings Estimates
Unitedhealth Group Inc (UNH) is presently subject to a detailed evaluation by 16.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $7.25, with high estimates of $7.91 and low estimates of $5.94.
Analysts are recommending an EPS of between $29.75 and $26.04 for the fiscal current year, implying an average EPS of $28.43. EPS for the following year is $32.72, with 26.0 analysts recommending between $34.4 and $29.5.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $112.75B this quarter.It ranges from a high estimate of $115.54B to a low estimate of $111.59B. As of the current estimate, Unitedhealth Group Inc’s year-ago sales were $98.86BFor the next quarter, 8 analysts are estimating revenue of $114.76B. There is a high estimate of $116.38B for the next quarter, whereas the lowest estimate is $113.42B.
A total of 21 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $458.27B, while the lowest revenue estimate was $448.1B, resulting in an average revenue estimate of $452.76B. In the same quarter a year ago, actual revenue was $400.28BBased on 22 analysts’ estimates, the company’s revenue will be $489.1B in the next fiscal year. The high estimate is $503.31B and the low estimate is $480.75B.
